JIC
Johnson Investment Counsel Portfolio holdings
AUM
$11.1B
This Quarter Return
+12.77%
1 Year Return
+15.75%
3 Year Return
+60.71%
5 Year Return
+113.42%
10 Year Return
+242.02%
AUM
$6B
AUM Growth
+$6B
(+11%)
Cap. Flow
+$54.4M
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
32.86%
Holding
618
New
45
Increased
223
Reduced
238
Closed
29
Top Buys
| 1 |
Visa
V
|
$46.3M |
| 2 |
Home Depot
HD
|
$18.1M |
| 3 |
Unilever
UL
|
$18.1M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$13.2M |
| 5 |
Procter & Gamble
PG
|
$10.5M |
Top Sells
| 1 |
Accenture
ACN
|
$83.5M |
| 2 |
TJX Companies
TJX
|
$21.2M |
| 3 |
First Hawaiian
FHB
|
$18M |
| 4 |
AT&T
T
|
$12.5M |
| 5 |
Colgate-Palmolive
CL
|
$10.8M |
Sector Composition
| 1 | Financials | 14.35% |
| 2 | Technology | 13.39% |
| 3 | Healthcare | 10.68% |
| 4 | Consumer Staples | 10.32% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Technology Select Sector SPDR Fund
XLK
$83.6B
| $3.38M | 0.06% |
25,981
+229
| +0.9% | +$29.8K |
|
152
Texas Instruments
TXN
$178B
| $3.35M | 0.06% |
20,421
+821
| +4% | +$135K |
|
153
Philip Morris
PM
$254B
| $3.29M | 0.05% |
39,139
-2,362
| -6% | -$198K |
|
154
iShares US Healthcare ETF
IYH
$2.75B
| $3.23M | 0.05% |
13,114
-947
| -7% | -$233K |
|
155
T Rowe Price
TROW
$23.2B
| $3.13M | 0.05% |
20,653
+110
| +0.5% | +$16.7K |
|
156
Intuitive Surgical
ISRG
$158B
| $2.93M | 0.05% |
3,575
-61
| -2% | -$49.9K |
|
157
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$4.52B
| $2.89M | 0.05% |
189,225
-10,973
| -5% | -$167K |
|
158
Stryker
SYK
$149B
| $2.89M | 0.05% |
11,742
+647
| +6% | +$159K |
|
159
CSX Corp
CSX
$60.2B
| $2.86M | 0.05% |
31,535
-191
| -0.6% | -$17.3K |
|
160
McCormick & Company Non-Voting
MKC
$18.7B
| $2.85M | 0.05% |
29,692
+14,857
| +100% | +$2.11K |
|
|
RP
161
DELISTED
RealPage, Inc.
RP
| $2.85M | 0.05% |
32,654
+6,389
| +24% | +$557K |
|
162
Xylem
XYL
$34B
| $2.83M | 0.05% |
27,753
-4,939
| -15% | -$503K |
|
163
Mondelez International
MDLZ
$79.3B
| $2.71M | 0.05% |
46,130
-618
| -1% | -$36.3K |
|
164
Chemed
CHE
$6.7B
| $2.71M | 0.05% |
5,085
+20
| +0.4% | +$10.7K |
|
165
Vanguard S&P 500 ETF
VOO
$724B
| $2.67M | 0.04% |
7,765
+1,094
| +16% | +$376K |
|
166
Tyler Technologies
TYL
$24B
| $2.65M | 0.04% |
6,074
-123
| -2% | -$53.7K |
|
167
Target
TGT
$42B
| $2.57M | 0.04% |
14,574
+537
| +4% | +$94.8K |
|
168
Vanguard Dividend Appreciation ETF
VIG
$95.1B
| $2.55M | 0.04% |
18,068
+4,358
| +32% | +$615K |
|
169
Invesco S&P 500 Low Volatility ETF
SPLV
$7.97B
| $2.52M | 0.04% |
44,855
+75
| +0.2% | +$4.22K |
|
170
LKQ Corp
LKQ
$8.23B
| $2.49M | 0.04% |
70,739
-3,599
| -5% | -$127K |
|
171
iShares MSCI Emerging Markets ETF
EEM
$19B
| $2.49M | 0.04% |
48,158
-943
| -2% | -$48.7K |
|
172
iShares Core S&P Total US Stock Market ETF
ITOT
$75B
| $2.44M | 0.04% |
28,274
+3,255
| +13% | +$281K |
|
173
Globus Medical
GMED
$7.94B
| $2.41M | 0.04% |
37,005
+584
| +2% | +$38.1K |
|
174
Allstate
ALL
$53.9B
| $2.35M | 0.04% |
21,220
-2,443
| -10% | -$270K |
|
175
Linde
LIN
$221B
| $2.33M | 0.04% |
8,857
-143
| -2% | -$37.7K |
|